Introduction: To evaluate the efficacy of oral rehydration therapy (ORT) in restoring water and electrolyte balance post-colectomy. Methods: Blinded placebo-controlled randomised cross-over trial. 30 patients with demonstrated hyperaldosteronism from the on-going observational study were recruited. Patients were randomised to receive either placebo or ORT first in a cross-over trial. Fasting urine and blood samples were collected to measure sodium loss, hydration status and renin-angiotensin-aldosterone system (RAAS) activation. Oral glucose tolerance test was performed. Health related quality of life (HRQoL) was assessed using SF-36 and FACIT-F questionnaires. Results: Observational study:60 FAP patients who had undergone colectomy were recruited. 27 patients (45%) demonstrated fasting hyperaldosteronism (>250pmol/L) leading to higher urinary losses of potassium (p¼0.03) and creatinine (p¼0.01). 19 patients 32%) demonstrated postprandial hypoglycaemia(<3.9mmol/L). Cross-over RCT Biochemistry results: Data acquired so far in 16 patients (n¼48 clinic visits) demonstrated fasting plasma aldosterone concentration post-ORT to be significantly lower compared to baseline [189.25 (7.24) Introduction: The management of an incidental Meckels diverticulum (MD) remains controversial. Current practice guidelines suggests that age less than 50 years, male sex and diverticulum length greater than 2cm are factors favouring resection. The aim of this study was to review a regional experience of resected Meckel's diverticulae. Methods: All resected specimens over a 17year period (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) were identified from patient clinical records, theatre logbooks, Hospital In-Patient Enquiry data and pathology databases across four hospital sites in Leinster, Ireland. Patient demographics and clinicopathological characteristics were reviewed. Results: Ninety-four MD were identified. The average age at surgery was 43.5 years (range 13-84 years) and 66% of patients were male. The majority presented symptomatically (n¼65), with abdominal pain and rectal bleeding the most common symptoms. Patients presenting symptomatically were significantly younger than patients with an incidental finding of MD (p¼0.02, Mann-Whitney U test) and 73% of symptomatic patients were male (p¼0.03, Mann-Whitney U test). Seventy-five per cent of specimens were 2cm or greater in length with no difference detected between the symptomatic and incidental groups. Ectopic mucosa was detected in 21 specimens and no malignancies were detected. Conclusions: This data suggests the decision to resect should be on an individual case basis. Introduction: To determine the rate of success of the ERAS pathways in colorectal and HPB surgery, but also relating compliance and its impact on ERAS success. Methods: Pre-, peri-and post-operative data of 56 colorectal and 9 HPB patients was collected prospectively between October and December 2013. Primary outcomes of ERAS success (% discharged on or before clinically expected day) and length of stay (days) were analysed using SPSS version 21.0 Results: ERAS success in colorectal surgery rose to 39.3% after a general decline from 2010-2012. Mean LOS for open and laparoscopic colorectal procedures were reduced by 2.8 and 2.6 days respectively. After univariate analysis 24 protocols were significantly associated with colorectal success. Further multivariate analysis established 12 including PCA or epidural removal before 12.00am (p¼0.004), urinary catheter removal (p¼0.005) and length of surgery (p¼0.017). HPB saw a slight drop in ERAS success to 44.4%, only lunch consumption (p¼0.016) was significantly associated with ERAS success after univariate analysis. Conclusions: Improvement in colorectal ERAS success suggests effective revision of protocols. As before the HPB results are clinically irrelevant due to the small sample size. If recommendations put forward are implemented one would expect them to increase future ERAS success. Introduction: With an ageing population diagnosed with cancer, rigorous co-morbidity assessment is cornerstone to optimising treatment and improving quality of survivorship. The study primarily aimed to determine the feasibility of routine co-morbidity data collection using the validated ACE-27 questionnaire. Secondary aims included determining the optimal time and method of data collection. Methods: A retrospective mapping exercise (phase I; 6-months) examined the co-morbidity data availability within the MDT. Phase II prospectively collected co-morbidity data using ACE-27 for a 3-month period. Results: In phase I, 73/135(54%) patients had co-morbidity data available informing the MDT discussion. In 62-patients with no co-morbidity data, assessment revealed 41(30%) to have co-morbidities including > 2 major system disorders in 21(16%) patients. Common referral sources to the MDT were surgical out-patients (42%), and endoscopy (13%). The average lead time from referral to index MDT discussion was 14-days. In phase II, ACE-27 was administered in 50-patients, mean age-54-years (range 20-84). Male: female ratio 26: 24. Average time to administer ACE-27 was 4.8minutes (range 1-15). Conclusions: The phase I study confirmed the previously widely acknowledged view of poor co-morbidity data availability within a CRC Abstracts / International Journal of Surgery 12 (2014) S13eS117 S34
